Effect of timing of heparin injection on acute STEMI treatment

Phase 3

Recruiting

• Conditions: Acute myocardial infarction with ST elevation.; ST elevation (STEMI) myocardial infarction of anterior wall; I21.0

• Registration Number: IRCT20200510047380N1
• Lead Sponsor: Vice-Chancellor For Research and Technology of Guilan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 13 July 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 120

Inclusion Criteria

Patients with STEMI who are willing to participate in this study

Exclusion Criteria

Patients receiving thrombotic medicine during past seven days
Pregnancy
Active bleeding
Thrombocytopenia history with heparin
Receiving heparin before hospitalization
History of thrombocytopenia
History of CABG
Age over 75
Failed Primary PCI

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
TIMI Flow grade. Timepoint: Once during coronary Angiography and before angioplasty, then after Primary PCI over culprit vessel. Method of measurement: Coronary Angiography.

Secondary Outcome Measures

Name	Time	Method
eft Ventricular Ejection Fraction (LVEF). Timepoint: 40 days after STEMI. Method of measurement: Echocardiography.;Pericardial effusion. Timepoint: 40 days after STEMI. Method of measurement: Echocardiography.;Free wall rupture. Timepoint: 40 days after STEMI. Method of measurement: Echocardiography.;FLAIL Mitral valve. Timepoint: 40 days after STEMI. Method of measurement: Echocardiography.;Ventricular Septal Rupture (VSR). Timepoint: 40 days after STEMI. Method of measurement: Echocardiography.